We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 1,812

Life sciences: product regulation and liability in Switzerland
  • Bär & Karrer
  • Switzerland, Global
  • April 23 2018

A structured guide to product regulation and liability laws in Switzerland


Life sciences: product regulation and liability in Turkey
  • NSN Law Firm
  • Turkey, Global
  • April 13 2018

A structured guide to product regulation and liability laws in Turkey


Life sciences: product regulation and liability in China
  • Ropes & Gray LLP
  • China, Global
  • March 15 2018

A structured guide to product regulation and liability laws in China


Life sciences: product regulation and liability in Japan
  • YUASA and HARA
  • Global, Japan
  • March 14 2018

A structured guide to product regulation and liability laws in Japan


Life sciences: product regulation and liability in Germany
  • Eversheds Sutherland (International) LLP
  • Germany
  • March 14 2018

A structured guide to product regulation and liability laws in Germany


Life Sciences: product regulation and liability in France
  • Reed Smith LLP
  • France, Global
  • March 2 2018

A structured guide to product regulation and liability laws in France


Life Sciences: product regulation and liability in Greece
  • KYRIAKIDES GEORGOPOULOS Law Firm
  • Global, Greece
  • February 22 2018

A structured guide to product regulation and liability laws in Greece


CRISPR: The New Frontier of Biotechnology Innovation
  • Paul Hastings LLP
  • USA
  • February 22 2018

By now, life sciences IP attorneys have probably heard about clustered regularly interspaced short palindromic repeats. In short, they are the


Patent Office’s Rulebook Update Supports Personalized Medicine Claims
  • Arent Fox LLP
  • USA
  • February 20 2018

Personalized medicine patent claims have been under assault since the Supreme Court’s Mayo v. Prometheus decision.1 At best, patent owners and


10 Trends to Watch in 2018
  • Manatt Phelps & Phillips LLP
  • USA
  • February 7 2018

Expect the shared federal-state responsibility for funding and operating Medicaid to be tested in new ways, with potentially profound ramifications